Actively Recruiting
Assessing Fluid-responsiveness Using Non-invasive Hybrid Diffuse Optics on Peripheral Muscle
Led by Corporacion Parc Tauli · Updated on 2026-03-18
200
Participants Needed
1
Research Sites
103 weeks
Total Duration
On this page
Sponsors
C
Corporacion Parc Tauli
Lead Sponsor
I
Institut de Ciències Fotòniques (ICFO)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Proof-of-concept observational study including ICU patients undergoing a PLR maneuver. Local microvasculature will be assessed with the hDOS platform on the brachioradialis muscle, deriving the microvascular blood flow index (BFI) and tissue oxygen saturation (StO2). CO will be assessed via an invasive hemodynamic monitor based on pulse waveform analysis through the patient's arterial line. The correlation over time between CO and microvascular parameters, and the ability of microvascular variables for predicting a positive CO response (increase \> 10%) will be assessed.
CONDITIONS
Official Title
Assessing Fluid-responsiveness Using Non-invasive Hybrid Diffuse Optics on Peripheral Muscle
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Invasive blood pressure monitoring through an arterial line
You will not qualify if you...
- Patients with suspected pregnancy
- Intra-abdominal hypertension
- Elevated intracranial pressure
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Parc Taulí Hospital Universitari
Sabadell, Spain/ Barcelona, Spain, 08208
Actively Recruiting
Research Team
J
Jaume Mesquida Senior Clinical Researcher, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here